Malaria vaccine: WHO position paper-January 2016

Wkly Epidemiol Rec. 2016 Jan 4;91(4):33-51.
[Article in En, French]
No abstract available

MeSH terms

  • Clinical Trials, Phase III as Topic
  • Cost-Benefit Analysis
  • Humans
  • Immunity, Innate
  • Infant
  • Malaria Vaccines / adverse effects
  • Malaria Vaccines / therapeutic use*
  • Malaria, Falciparum / diagnosis
  • Malaria, Falciparum / prevention & control*
  • Plasmodium falciparum / immunology*
  • World Health Organization*

Substances

  • Malaria Vaccines